Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BEI Medical Systems Co. Inc.

Division of Boston Scientific Corp.
www.beimedical.com

Latest From BEI Medical Systems Co. Inc.

Medtech Start-Ups Innovate In Minimally Invasive Gynecology

Medtech start-ups are taking on the global endometrial ablation and uterine artery embolization markets with next-generation systems designed to raise the standard of care in menorrhagia treatment. Profiles of Channel Medsystems, EmboMedics, and Minerva Surgical.

Medical Device

Novacept: A Patient Device Exit Strategy Succeeds

Using an aggressive clinical trials strategy to overcome early setbacks, Novacept is proof a small company can succeed in a big company market, and that a patient exit strategy can pay off for device companies--evidenced by Cytyc's $325 million cash acquisition of Novacept.
Medical Device Strategy

Impres Medical Inc.

Impres Medical Inc. aims to offer women an office-based non-surgical solution for menorrhagia. The start-up has developed an implantable device that replicates Asherman's syndrome, a disorder that forces a buildup of fibrous tissue in the uterus that replaces the endometrium and eventually deactivates the menstrual cycle.
Medical Device

Medical Acquisitions: No Icebreaker in Sight

At the top of the industry, consolidation has frozen out much additional M&A; horizontal mergers among large companies have become much more difficult to get through regulatory authorities as the industries themselves have consolidated. In medical devices, M&A is at a 10-year low, reflecting a paucity of high-value small-company opportunities. Perhaps as important, some successful big-company development programs undermine a basic assumption of medical device investing: that big companies must source innovation from small ones, usually through acquisitions. Meanwhile In biotech, the number and value of M&A is down, despite the apparent logic of consolidation and the unprecedented willingness of sellers to accept low valuations. The key problem is that there are few buyers: those without extremely strong balance sheets aren't willing to take on additional burn rates, having seen some acquirers come to grief as their new, apparently stronger companies are unable to raise money in this bear market.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Richard W Turner, PhD, Pres. & CEO
    Thomas W Fry, VP, Fin. & Admin.
    John J Gormally, VP, Sales
    Samuel Dickstein, VP, New Bus. Dev. & Tech.
  • Contact Info
  • BEI Medical Systems Co. Inc.
    Phone: (201) 727-4900
    100 Hollister Rd.
    Teterboro, NJ 07608
    USA
UsernamePublicRestriction

Register